Skip to content

H2020HORIZONFP7

Asociacion Centro de Investigacion Cooperativa en Biociencias

Country
ESSpain
Defence projects
0
Projects, all programmes
45
As coordinator
25
EU contribution (CORDIS)
EUR 20,250,347
Active
2008 to 2025

Projects

45 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
GLYTUNESA multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axisH20202021ParticipantEUR 250,905
MyeRIBODeconstructing the Translational Control of Myelination by Specialized RibosomesH20202020ParticipantEUR 14,477
QS21-MechTarget identification and elucidation of the molecular mechanism of action of saponin vaccine adjuvants QS-21 (QS21Mech)H20202020CoordinatorEUR 172,932
GlycoMabsChemoenzymatic glyco-engineering of therapeutic monoclonal antibodiesH20202019CoordinatorEUR 160,932
NextGen IOExploiting the hypoxia response in T cells for Next-Generation Immuno-OncologyH20202019CoordinatorEUR 1,993,575
proEVLifeCycleThe life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevanceH20202019ParticipantEUR 250,905
CancerADAPTTargeting the adaptive capacity of prostate cancer through the manipulation of transcriptional and metabolic traitsH20202019CoordinatorEUR 1,999,882
BactiVaxanti-Bacterial Innovative Vaccine Training Network.H20202019ParticipantEUR 501,810
RECGLYCANMRBreaking the limits in glycan recognition by NMRH20202018CoordinatorEUR 2,499,980
UbiCODEEuropean Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targetsH20202018ParticipantEUR 247,873
LITMUSLiver Investigation: Testing Marker Utility in SteatohepatitisH20202017ParticipantEUR 403,018
ADJUV-ANT VACCINESElucidating the Molecular Mechanisms of Synthetic Saponin Adjuvants and Development of Novel Self-Adjuvanting VaccinesH20202017CoordinatorEUR 1,499,219
MetaboMARKERA metabolism-based prognostic biomarker for prostate cancerH20202017CoordinatorEUR 150,000
FCSSSLPFirst Chemoselective Synthesis and Structural Studies of Lasso PeptidesH20202016CoordinatorEUR 257,191
TRAINTribbles Research and Innovation NetworkH20202016ParticipantEUR 297,448
ACMCholesterol metabolism as a driver of prostate cancer aggressivenessH20202015CoordinatorEUR 158,122
SchmaVirusVacDiagNovel vaccine and diagnostic strategies against Schmallenberg virusH20202015CoordinatorEUR 158,122
GLYCOVAXA training network for the rational design of the next generation of well-defined glycoconjugate vaccinesH20202015ParticipantEUR 247,873
TOLLerantToll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach.H20202015ParticipantEUR 247,873
THE NASCENT CODEUnravelling the Nascent Code: Signals sensed and transmitted by the nascent chain to acquire its functional state or reprogram gene expressionH20202014CoordinatorEUR 100,000

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.